These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19995654)
1. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients]. Prévost A; Papathanassiou D; Jovenin N; Menéroux B; Cuif-Job A; Bruna-Muraille C; Domange-Testard A; Liehn JC Rev Pneumol Clin; 2009 Dec; 65(6):341-9. PubMed ID: 19995654 [TBL] [Abstract][Full Text] [Related]
2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
3. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer. Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929 [TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
5. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
7. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT for staging of penile cancer. Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528 [TBL] [Abstract][Full Text] [Related]
9. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
10. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer. Groheux D; Moretti JL; Baillet G; Espie M; Giacchetti S; Hindie E; Hennequin C; Vilcoq JR; Cuvier C; Toubert ME; Filmont JE; Sarandi F; Misset JL Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):695-704. PubMed ID: 18436392 [TBL] [Abstract][Full Text] [Related]
11. Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging. Krüger S; Mottaghy FM; Buck AK; Maschke S; Kley H; Frechen D; Wibmer T; Reske SN; Pauls S Nuklearmedizin; 2011; 50(3):101-6. PubMed ID: 21165538 [TBL] [Abstract][Full Text] [Related]
12. Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Lee HY; Hyun SH; Lee KS; Kim BT; Kim J; Shim YM; Ahn MJ; Kim TS; Yi CA; Chung MJ Ann Surg Oncol; 2010 Oct; 17(10):2787-94. PubMed ID: 20461469 [TBL] [Abstract][Full Text] [Related]
13. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Bruzzi JF; Komaki R; Walsh GL; Truong MT; Gladish GW; Munden RF; Erasmus JJ Radiographics; 2008; 28(2):561-72. PubMed ID: 18349458 [TBL] [Abstract][Full Text] [Related]
15. [The role of PET in lung cancer staging]. Gärtner FC; Buermann J; Skowasch D; Biersack HJ; Essler M Dtsch Med Wochenschr; 2015 Apr; 140(9):679-83. PubMed ID: 25924049 [TBL] [Abstract][Full Text] [Related]
16. [The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)]. Zsiray M; Markóczy Z; Magyar M; Lengyel Z; Fekésházy A; Borbély K Magy Onkol; 2009 Mar; 53(1):17-21. PubMed ID: 19318322 [TBL] [Abstract][Full Text] [Related]
17. PET/CT for staging and monitoring non small cell lung cancer. Rankin S Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S27-31. PubMed ID: 18852078 [TBL] [Abstract][Full Text] [Related]
18. Current state of imaging for lung cancer staging. Kent MS; Port JL; Altorki NK Thorac Surg Clin; 2004 Feb; 14(1):1-13. PubMed ID: 15382304 [TBL] [Abstract][Full Text] [Related]